Epigenomics Ag Stock Volatility

EPGNF Stock  USD 0.50  0.00  0.00%   
Epigenomics is out of control given 3 months investment horizon. Epigenomics AG secures Sharpe Ratio (or Efficiency) of 0.1, which denotes the company had a 0.1% return per unit of risk over the last 3 months. We were able to interpolate sixteen different technical indicators, which can help you to evaluate if expected returns of 5.25% are justified by taking the suggested risk. Use Epigenomics Standard Deviation of 50.36, mean deviation of 11.97, and Variance of 2536.13 to evaluate company specific risk that cannot be diversified away. Key indicators related to Epigenomics' volatility include:
660 Days Market Risk
Chance Of Distress
660 Days Economic Sensitivity
Epigenomics Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Epigenomics daily returns, and it is calculated using variance and standard deviation. We also use Epigenomics's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Epigenomics volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Epigenomics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Epigenomics at lower prices. For example, an investor can purchase Epigenomics stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Epigenomics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Epigenomics Market Sensitivity And Downside Risk

Epigenomics' beta coefficient measures the volatility of Epigenomics pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Epigenomics pink sheet's returns against your selected market. In other words, Epigenomics's beta of -14.01 provides an investor with an approximation of how much risk Epigenomics pink sheet can potentially add to one of your existing portfolios. Epigenomics AG is displaying above-average volatility over the selected time horizon. Epigenomics AG is a potential penny stock. Although Epigenomics may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Epigenomics AG. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Epigenomics instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Epigenomics AG Demand Trend
Check current 90 days Epigenomics correlation with market (NYSE Composite)

Epigenomics Beta

    
  -14.01  
Epigenomics standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  52.4  
It is essential to understand the difference between upside risk (as represented by Epigenomics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Epigenomics' daily returns or price. Since the actual investment returns on holding a position in epigenomics pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Epigenomics.

Epigenomics AG Pink Sheet Volatility Analysis

Volatility refers to the frequency at which Epigenomics pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Epigenomics' price changes. Investors will then calculate the volatility of Epigenomics' pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Epigenomics' volatility:

Historical Volatility

This type of pink sheet volatility measures Epigenomics' fluctuations based on previous trends. It's commonly used to predict Epigenomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Epigenomics' current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Epigenomics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Epigenomics AG Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Epigenomics Projected Return Density Against Market

Assuming the 90 days horizon Epigenomics AG has a beta of -14.0137 suggesting as returns on its benchmark rise, returns on holding Epigenomics AG are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Epigenomics is expected to outperform its benchmark.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Epigenomics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Epigenomics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Epigenomics pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Epigenomics AG has an alpha of 6.5799, implying that it can generate a 6.58 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Epigenomics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how epigenomics pink sheet's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Epigenomics Price Volatility?

Several factors can influence a pink sheet's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Epigenomics Pink Sheet Risk Measures

Assuming the 90 days horizon the coefficient of variation of Epigenomics is 998.8. The daily returns are distributed with a variance of 2745.36 and standard deviation of 52.4. The mean deviation of Epigenomics AG is currently at 12.94. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.56
α
Alpha over NYSE Composite
6.58
β
Beta against NYSE Composite-14.01
σ
Overall volatility
52.40
Ir
Information ratio 0.09

Epigenomics Pink Sheet Return Volatility

Epigenomics historical daily return volatility represents how much of Epigenomics pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 52.3961% volatility of returns over 90 . By contrast, NYSE Composite accepts 0.5731% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Epigenomics Volatility

Volatility is a rate at which the price of Epigenomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Epigenomics may increase or decrease. In other words, similar to Epigenomics's beta indicator, it measures the risk of Epigenomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Epigenomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.
Epigenomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Epigenomics Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Epigenomics' price varies over time.

3 ways to utilize Epigenomics' volatility to invest better

Higher Epigenomics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Epigenomics AG stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Epigenomics AG stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Epigenomics AG investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Epigenomics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Epigenomics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Epigenomics Investment Opportunity

Epigenomics AG has a volatility of 52.4 and is 91.93 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Epigenomics AG is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use Epigenomics AG to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Epigenomics to be traded at $0.495 in 90 days.

Good diversification

The correlation between Epigenomics AG and NYA is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Epigenomics AG and NYA in the same portfolio, assuming nothing else is changed.

Epigenomics Additional Risk Indicators

The analysis of Epigenomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Epigenomics' investment and either accepting that risk or mitigating it. Along with some common measures of Epigenomics pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Epigenomics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Epigenomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Epigenomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Epigenomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Epigenomics AG.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epigenomics AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Epigenomics Pink Sheet analysis

When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between Epigenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Epigenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Epigenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.